We noted significant population differences between healthy volunteers (control) and FXS patients in ACO2 and RAS, with a trend level difference in HK1 with all three proteins having decreased expression compared to controls (Fig. 5a, b). The gene discussed is HK1; the disease is fragile X syndrome.